Filing Details
- Accession Number:
- 0001225208-13-016850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-29 16:44:42
- Reporting Period:
- 2013-07-29
- Filing Date:
- 2013-07-29
- Accepted Time:
- 2013-07-29 16:44:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1198959 | M James Cornelius | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Acquisiton | 2013-07-29 | 2,500 | $26.25 | 644,883 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2013-07-29 | 2,500 | $24.96 | 647,383 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2013-07-29 | 5,000 | $43.81 | 642,383 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2013-07-29 | 2,500 | $0.00 | 2,500 | $24.96 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2013-07-29 | 2,500 | $0.00 | 2,500 | $26.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-05-01 | No | 4 | M | Direct | |
0 | 2015-05-02 | No | 4 | M | Direct |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.81 to $43.82, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 2, 2006.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 3, 2005.